Keeping Current
Solving the Puzzles for B-Cell Malignancies: Navigating the Place of BTK Inhibitors Today and Tomorrow
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 1:32:13
- Mas informaciones
Informações:
Sinopsis
Did you know that using Bruton tyrosine kinase (BTK) inhibitors can lead to chemotherapy-free regimens for treating certain B-cell malignancies? Credit available for this activity expires: 11/7/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/983523?src=mkm_podcast_addon_983523
